- Home
- OSUR vs KPTI Comparison
OSUR vs KPTI Comparison
Compare OSUR & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | KPTI |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.1M | 172.6M |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OSUR | KPTI |
|---|---|---|
| Price | $3.01 | $8.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $3.00 | ★ $17.50 |
| AVG Volume (30 Days) | 437.4K | ★ 594.8K |
| Earning Date | 05-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $167,064,000.00 | $146,067,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.76 | $46.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $2.08 | $3.51 |
| 52 Week High | $4.22 | $10.99 |
Technical Indicators
Market Signals| Indicator | OSUR | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 49.70 |
| Support Level | $2.98 | $5.60 |
| Resistance Level | $3.12 | $8.95 |
| Average True Range (ATR) | 0.23 | 0.75 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 52.66 | 40.07 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).